Examples of this new social development in medicine includes the personalised medicine summit taking
place in the Life Science Institute,
University of British Columbia , in
partnership with the Personalized
Medicine Initiative, Genome BC and
LifeScience BC on Sunday 7th-9th of
June this year. Professor Terry Allen,
Conference Organizer, describes that
“in many ways, British Columbia
(BC) constitutes an ideal testing
ground for putting a personalised
medicine rogramme into practice,
with its highly integrated singlepayer health care system, its ethnically diverse, well-educated population and its advanced expertise in
the development and application of
molecularly-based medicine .” This
scheme aims to use pharmacogenomics and other ‘omics’ analyses to
guide diagnosis and treatment and
manage, interpret and use big data
in a new system of data consolidation to access improving health care
in BC and investment in basic and
translational research to advance
personalized medicine discoveries.
This aims to create a better knowledge of the maintenance of wellness
in the public and eventually create
6
new development in personalised
medicine beyond what has already
been discovered.
Another example of the progress
and breadth that personalised medicine has reached is in the PMWC
(personalised medicine world conference) held in Silicon Valley 2014. This
conference provides the entire range
of people involved in personalise
medicine, and each speaker gives a
unique take on the developments of
the future. Brook Byers, senior partner in KPCB (Kleiner Perkins Caufield
& Byers), even goes as far to say
that “this is the best personalised
medicine conference there is today
.” From 400 attenders and 41 speakers in 2010 to 1000+ attendees and
100+ speakers, is it clear to see
there is growing interest in the area
of personalised medicine with more
than 40 companies investing in the
development of the scheme, socially
and technologically.